| 54.56 Data as of May 23 |  -0.49 / -0.89%Today’s Change | 33.03 Today|||52-Week Range 55.86 | +15.15% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $145.7B |
Company Description
Sanofi engages in the research, production and distribution of pharmaceutical products. The company operates through the following segments: Pharmaceuticals, Human Vaccines and Animal Health. The Pharmaceuticals segment includes research, development, production and sales activities relating to pharmaceutical products, including prescription, consumer health care, and generic products. This segment also includes equity affiliates and joint ventures with pharmaceutical business activities. The Human Vaccines segment includes research, development, production and marketing. The Animal Health segment comprises the research, development, production and marketing activities for vaccines. It offers a range of medicines and vaccines on animal species. The company was founded in 1994 and is headquartered in Paris, France.
Employees
Shareholders
| Other institutional | 5.23% |
| Mutual fund holders | 3.21% |
| Individual stakeholders | -- |
Top Executives
| Christopher A. Viehbacher, CPA | Chief Executive Officer & Director |
| Hanspeter Spek | President-Global Operations |
| Jérôme Contamine | Chief Financial Officer & Executive Vice President |
| Paul Chew, PhD | Chief Medical Officer & Senior Vice President |
| Jorge Insuasty, MD | VP, Deputy President-Research & Development |
.
